Author name: admin

Two weeks before our Annual meeting, organized by IBM partners to take place in TelAviv, Israel, the media bring us the news about the terrible inhuman terror attack on civilians in Israel. The EuCARE partners are devastated and deeply saddened with the violence and war in the region and hope for peace to come. Particularly […]

This new study, published yesterday, 3rd of October by the EuCARE partners from the Vilnius University Hospital Santaros Klinikos (VULSK), in the British Journal of Haematology, shows improved protection against Omicron infection and severe COVID-19 for those who received a third (booster) dose of mRNA vaccine. In this study, the final cohort included 912 patients

This year, once again, the EuCARE project was present on the European Researchers’ Night in two European cities: Lisbon and Rome! Last Friday and Saturday, 29th and 30th of September, EuCARE researchers were present in two venues Europe-wide to promote activities of science dissemination related to the EuCARE project. The action disseminated the work developed

The COVID-19 pandemic pushed education from schools to educational technologies at a pace and scale with no historical precedent. For hundreds of millions of students, schools closure lead to formal learning becoming fully dependent on technology. This new book published by Unesco “An ed-tech tragedy? Educational technologies and school closures in the time of COVID-19”

A new publication, published on 4th of September by the EuCARE partners Pontus Hedberg and Pontus Nauclér from Karoliska Institute, shows a reduced risk of acquiring Post-COVID Condition (PCC) after a primary infection with omicron variant when compared to older variants. In this report, there were 215,279 individuals in the omicron cohort, 52,182 in the

Portugal and Mexico are going to restart the “Lolli” testing in schools to complete the second period of testing. The EuCARE schools study was completed in Italy between November 2022 and June 2023. As planned, two periods of SARS-CoV-2 testing occurred with crossover of classes between control and intervention groups. In Portugal and Mexico, the

The EuCARE clinical cohorts have enrolled overall more than 44.000 patients The clinical cohorts studies have been set up to evaluate the association between circulating SARS-CoV-2 variants and the risk of developing short, mid and long-term clinical outcomes. The EuCARE partners, until now, enrolled a total of 44,260 patients and Health Care Workers. The three

Get to know more: A brief summary of the two oral presentations given by Elham Shamsara! Nico Pfeifer, Elham Shamsara, and Florian König from the Eberhard Karls Universitaet Tuebingen (EKUT), attended the GMDS/IBS-DR joint workshop on Computational Models in Biology and Medicine 2023 in Stuttgart. Elham on June 16th presented their work entitled: “A COVID-19

The EuCARE consortium maintains and regularly updates a unique library of SARS-CoV-2 virus isolates providing invaluable biological material for research. So far, the EuCARE library of variants accumulated a total of 54 different SARS-CoV-2 variants. Please contact EuCARE if you are interested in performing studies using those variants. Check the library in https://eucareresearch.eu/eucare-library-of-variants/

School year 2022-2023 has finished! EuCARE partners in Italy, Mexico and Portugal have worked hard to advance the data collection for the schools cohort. Preliminary results are promising and indicate that the Lolli-Methode may be useful to decrease SARS-CoV-2 infections in the school setting and that sadness and anger were the emotions more frequently experienced